Personensuche
Personensuche
Es wurde 1 Person gefunden.
Marienhospital Bottrop
Marienhospital Bottrop
Funktionen
-
Nebenberuflich Lehrende/r, Klinik für Frauenheilkunde und Geburtshilfe
Aktuelle Veranstaltungen
Keine aktuellen Veranstaltungen.
Vergangene Veranstaltungen (max. 10)
Keine vergangenen Veranstaltungen.
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
Breast Conserving Surgery in Combination With Targeted Intraoperative Radiotherapy Compared to Mastectomy for In-breast-tumor-recurrenceIn: Anticancer Research Jg. 43 (2023) Nr. 2, S. 733 - 739Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Ratios of monocytes and neutrophils to lymphocytes in the blood predict benefit of CDK4/6 inhibitor treatment in metastatic breast cancerIn: Scientific Reports Jg. 13 (2023) Nr. 1, 21262Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Significantly longer time to deterioration of quality of life due to CANKADO PRO-React eHealth support in HR+ HER2− metastatic breast cancer patients receiving palbociclib and endocrine therapy : Primary outcome analysis of the multicenter randomized AGO-B WSG PreCycle trialIn: Annals of Oncology Jg. 34 (2023) Nr. 8, S. 660 - 669Online Volltext: dx.doi.org/ (Open Access)
-
Update Breast Cancer 2023 Part 1 : Early Stage Breast CancerIn: Geburtshilfe und Frauenheilkunde Jg. 83 (2023) Nr. 6, S. 653 - 663Online Volltext: dx.doi.org/ (Open Access)
-
Update Breast Cancer 2023 Part 2 : Advanced-Stage Breast CancerIn: Geburtshilfe und Frauenheilkunde Jg. 83 (2023) Nr. 06, S. 664 - 672Online Volltext: dx.doi.org/ (Open Access)
-
Update Breast Cancer 2023 Part 3 : Expert Opinions of Early Stage Breast Cancer TherapiesIn: Geburtshilfe und Frauenheilkunde Jg. 83 (2023) Nr. 09, S. 1117 - 1126Online Volltext: dx.doi.org/ (Open Access)
-
Update Mammakarzinom 2022 Teil 5 : Brustkrebs in frühen KrankheitsstadienIn: Geburtshilfe und Frauenheilkunde Jg. 83 (2023) Nr. 3, S. 289 - 298Online Volltext: dx.doi.org/ (Open Access)
-
Update Mammakarzinom 2022 Teil 6 : Brustkrebs in fortgeschrittenen KrankheitsstadienIn: Geburtshilfe und Frauenheilkunde Jg. 83 (2023) Nr. 3, S. 299 - 309Online Volltext: dx.doi.org/ (Open Access)
-
The Role of C-Reactive Protein as a Prognostic Biomarker in Patients with Early Breast Cancer Treated with Neoadjuvant ChemotherapyIn: Breast Care Jg. 17 (2022) Nr. 4, S. 371 - 376Online Volltext: dx.doi.org/ (Open Access)
-
Update Breast Cancer 2021 Part 4 : Prevention and Early StagesIn: Geburtshilfe und Frauenheilkunde Jg. 82 (2022) Nr. 2, S. 206 - 214Online Volltext: dx.doi.org/ (Open Access)
-
Update Breast Cancer 2021 Part 5 : Advanced Breast CancerIn: Geburtshilfe und Frauenheilkunde Jg. 82 (2022) Nr. 2, S. 215 - 225Online Volltext: dx.doi.org/ (Open Access)
-
Update Breast Cancer 2022 Part 3 : Early-Stage Breast CancerIn: Geburtshilfe und Frauenheilkunde Jg. 82 (2022) Nr. 9, S. 912 - 921Online Volltext: dx.doi.org/ (Open Access)
-
Update Breast Cancer 2022 Part 4 - Advanced-Stage Breast CancerIn: Geburtshilfe und Frauenheilkunde Jg. 82 (2022) Nr. 9, S. 922 - 931Online Volltext: dx.doi.org/ (Open Access)
-
Integrative statistical analyses of multiple liquid biopsy analytes in metastatic breast cancerIn: Genome Medicine Jg. 13 (2021) Nr. 1, 85Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Update Breast Cancer 2021 Part 1 : Prevention and Early StagesIn: Geburtshilfe und Frauenheilkunde Jg. 81 (2021) Nr. 5, S. 526 - 538Online Volltext: dx.doi.org/ (Open Access)
-
Update Breast Cancer 2021 Part 2 : Advanced Stages, Long-Term Consequences and BiomarkersIn: Geburtshilfe und Frauenheilkunde Jg. 81 (2021) Nr. 5, S. 539 - 548Online Volltext: dx.doi.org/ (Open Access)
-
Update Mammakarzinom 2021 Teil 3 – aktuelle Entwicklungen bei der Behandlung von Brustkrebspatientinnen mit frühen Krankheitsstadien : Übersicht und Beurteilung von speziellen Therapiesituationen durch ein internationales ExpertenpanelIn: Geburtshilfe und Frauenheilkunde Jg. 81 (2021) Nr. 6, S. 654 - 665Online Volltext: dx.doi.org/ (Open Access)
-
Complementary and alternative medicine and musculoskeletal pain in the first year of adjuvant aromatase inhibitor treatment in early breast cancer patientsIn: The Breast Jg. 50 (2020) S. 11 - 18Online Volltext: dx.doi.org/ (Open Access)
-
Correction : Residual Axillary Burden After Neoadjuvant Chemotherapy (NACT) in Early Breast Cancer in Patients with a priori Clinically Occult Nodal Metastases – a transSENTINA AnalysisIn: Geburtshilfe und Frauenheilkunde Jg. 80 (2020) Nr. 12, S. E290Online Volltext: dx.doi.org/ (Open Access)
-
Residual Axillary Burden after Neoadjuvant Chemotherapy (NACT) in Early Breast Cancer in Patients with a priori Clinically Occult Nodal Metastases - A transSENTINA AnalysisIn: Geburtshilfe und Frauenheilkunde Jg. 80 (2020) Nr. 12, S. 1229 - 1236Online Volltext: dx.doi.org/ (Open Access)
-
The Abscopal Effect : Could a Phenomenon Described Decades Ago Become Key to Enhancing the Response to Immune Therapies in Breast Cancer?In: Breast Care Jg. 15 (2020) Nr. 5, S. 443 - 449Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
The role of Ki67 as a predictive biomarker for pathologic complete remission (pCR) in patients with HER2 positive early breast cancer (BC) receiving neoadjuvant chemotherapy (NACT) in combination with trastuzumab and pertuzumabIn: Geburtshilfe und Frauenheilkunde Jg. 80 (2020) Nr. 6, S. e49Online Volltext: dx.doi.org/
-
Association between breast cancer risk factors and molecular type in postmenopausal patients with hormone receptor-positive early breast cancerIn: Breast Cancer Research and Treatment Jg. 174 (2019) Nr. 2, S. 453 - 461Online Volltext: dx.doi.org/
-
Preexisting musculoskeletal burden and its development under letrozole treatment in early breast cancer patientsIn: International Journal of Cancer Jg. 145 (2019) Nr. 8, S. 2114 - 2121Online Volltext: dx.doi.org/
-
Re-Excision Rates in Breast-Conserving Surgery for Invasive Breast Cancer after Neoadjuvant Chemotherapy with and without the Use of a Radiopaque Tissue Transfer and X-ray SystemIn: Breast Care Jg. 14 (2019) Nr. 5, S. 302 - 307Online Volltext: dx.doi.org/ (Open Access)
-
RNA profiles of circulating tumor cells and extracellular vesicles for therapy stratification of metastatic breast cancer patientsIn: Clinical Chemistry Jg. 64 (2018) Nr. 7, S. 1054 - 1062Online Volltext: dx.doi.org/ (Open Access)
-
An Ultralow-Dose 1-Day Protocol With Activities Lower Than 20 MBq for the Detection of Sentinel Lymph Nodes in Breast Cancer—Experiences After 150 CasesIn: Technology in Cancer Research & Treatment (TCRT) Jg. 16 (2017) Nr. 6, S. 1079 - 1082Online Volltext: dx.doi.org/ (Open Access)
-
Clinical utility of neoadjuvant endocrine therapy for hormone receptor positive breast cancerIn: Reviews on Recent Clinical Trials Jg. 12 (2017) Nr. 2, S. 67 - 72Online Volltext: dx.doi.org/
-
Comparison of the PI3KCA pathway in circulating tumor cells and corresponding tumor tissue of patients with metastatic breast cancerIn: Molecular Medicine Reports Jg. 15 (2017) Nr. 5, S. 2957 - 2968Online Volltext: dx.doi.org/ (Open Access)
-
Interest in Integrative Medicine among Postmenopausal Hormone Receptor-Positive Breast Cancer Patients in the EvAluate-TM StudyIn: Integrative Cancer Therapies Jg. 16 (2017) Nr. 2, S. 165 - 175Online Volltext: dx.doi.org/ (Open Access)
-
Targeted Intraoperative Radiotherapy Tumour Bed Boost during Breast-Conserving Surgery after Neoadjuvant Chemotherapy - a Subgroup Analysis of Hormone Receptor-Positive HER2-Negative Breast CancerIn: Breast Care Jg. 12 (2017) Nr. 5, S. 318 - 323Online Volltext: dx.doi.org/ (Open Access)
-
Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS) : a double-blind, randomised controlled trialIn: Lancet Jg. 387 (2016) Nr. 10021, S. 866 - 873Online Volltext: dx.doi.org/ (Open Access)
-
Neoadjuvant Chemotherapy with Docetaxel, Carboplatin and Weekly Trastuzumab Is Active in HER2-Positive Early Breast Cancer : Results after a Median Follow-Up of over 4 YearsIn: Breast Care Jg. 11 (2016) Nr. 5, S. 323 - 327Online Volltext: dx.doi.org/
-
Neoadjuvant, anthracycline-free chemotherapy with carboplatin and docetaxel in triple-negative, early-stage breast cancer : a multicentric analysis of rates of pathologic complete response and survivalIn: Chemotherapy Jg. 28 (2016) Nr. 3, S. 210 - 217Online Volltext: dx.doi.org/ (Open Access)
-
Neoadjuvant, anthracycline-free chemotherapy with carboplatin and docetaxel in triple-negative, early-stage breast cancer : A multicentric analysis of feasibility and rates of pathologic complete responseIn: Chemotherapy Jg. 59 (2014) Nr. 5, S. 387 - 394Online Volltext: dx.doi.org/ (Open Access)
-
Updated results of neoadjuvant chemotherapy with carboplatin AUC 6 and docetaxel 75 mg/m2 in triple-negative breast cancer (TNBC)In: Journal of Clinical Oncology (JCO) Jg. 31 (2013) S. 149 - 149Online Volltext: dx.doi.org/
-
Neoadjuvant platin and bevacizumab in triple-negative breast cancerIn: Journal of Clinical Oncology (JCO) Jg. 29 (2011) Nr. 15_suppl, S. e11591Online Volltext: dx.doi.org/
-
Pathologic response rate (pCR) and near-pathologic response rate (near-pCR) with docetaxel-carboplatin (TCarb) in early triple-negative breast cancerIn: Journal of Clinical Oncology (JCO) Jg. 29 (2011) S. 277Online Volltext: dx.doi.org/
-
Breast preservation after local recurrence of breast cancer : Comparison of length and quality of life (QoL) between breast conserving surgery with intraoperative radiotherapy (TARGIT-IORT) versus mastectomyIn: Journal of Clinical Oncology (JCO) Jg. 40 (2022) Nr. 16_Suppl., S. e12573Online Volltext: dx.doi.org/ (Open Access)
-
Association between mammographic breast density and achievement of a pathologic complete remission (pCR) after neoadjuvant chemotherapy (NACT) for early breast cancer (EBC)In: Journal of Clinical Oncology (JCO) Jg. 39 (2021) Nr. 15_Suppl., S. e12611Online Volltext: dx.doi.org/
-
The role of C-reactive protein (CRP) as a prognostic biomarker in patients with early breast cancer (EBC) treated with neoadjuvant chemotherapy (NACT).In: Journal of Clinical Oncology (JCO) Jg. 39 (2021) Nr. 15_Suppl, S. e12545Online Volltext: dx.doi.org/
-
The role of Ki67 in involved lymph nodes as a predictive biomarker for response to neoadjuvant chemotherapy in patients with early breast cancer
2021 ASCO Annual Meeting, 4. - 8. June 2021, virtuell,In: Journal of Clinical Oncology (JCO) Jg. 39 (2021) Nr. 15_suppl, S. e12553Online Volltext: dx.doi.org/ (Open Access) -
Metastatic breast cancer subgroup specific mRNA profiles of circulating tumor cells and extracellular vesicles
AACR Annual Meeting 2020; April 27-28, 2020 and June 22-24, 2020; Philadelphia, USA,In: Cancer Research Jg. 80 (2020) Nr. Suppl. 16, S. 5366Online Volltext: dx.doi.org/ -
Use of unique molecular identifiers to gain insight about the true positive mutations in cfDNA of breast cancer patients for implementation of personalized treatmentIn: Cancer Research Jg. 79 (2018) Nr. Suppl. 13,Online Volltext: dx.doi.org/
-
Docetaxel, carboplatin and weekly trastuzumab are active as neoadjuvant therapy in operable HER2-positive breast cancerIn: The Breast Jg. 20 (2011) Nr. Suppl. 1, S. S74Online Volltext: dx.doi.org/
-
Primary systemic chemotherapy with carboplatin AUC 6 and docetaxel 75 mg/m2 (q3w) in triple-negative early breast cancer
2010 ASCO Annual Meeting, June 4-8, 2010, Chicago, Ill., USA,In: Journal of Clinical Oncology (JCO) Jg. 28 (2010) Nr. Suppl. 15, e11063Online Volltext: dx.doi.org/ -
Deeskalationsstrategien in der Therapie des Mammakarzinoms : systemtherapeutische und lokale Ansätze zur Reduktion der therapieassoziierten Morbidität bei gleicher onkologischer SicherheitDuisburg ; Essen (2017) 1 CD-ROM